Shanghai baiying pharmaceutical technology Co., Ltd.赞助的临床试验
总计926个结果
-
Suzhou Puhe Pharmaceutical Technology Co., LTD尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘PD-L1阳性(CPS≥1)的复发或转移性宫颈癌
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘远端对称性多发性神经病 (DSPN)
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.终止
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动,不招人
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.主动,不招人
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.撤销
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Hangzhou Yirui Pharmaceutical Technology Co., Ltd尚未招聘
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.尚未招聘